Skip to main content

E Fund Management Co., Ltd.

Position in DNLI — Denali Therapeutics Inc.

CIK 1842296 GUANGZHOU, F4

Position in DNLI

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$349,406
-$14,280 QoQ
Shares Held
13,585
-28.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#172
of 290 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

E Fund Management Co., Ltd. holds $66,079,043 across 109 Biotechnology names. DNLI ranks #56 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $349,406 13,585
2026-03-31 $363,686 18,942
2025-06-30 $190,431 13,612
2025-03-31 $164,078 12,069
2024-12-31 $203,738 9,997
2024-09-30 $220,251 7,561
2024-06-30 $213,624 9,200
2024-03-31 $421,727 20,552
2023-12-31 $371,043 17,290
2023-09-30 $243,042 11,781
2023-06-30 $394,283 13,361
2023-03-31 $336,821 14,619
2022-12-31 $413,284 14,861
2022-09-30 $437,455 14,254
2022-06-30 $342,594 11,641
2022-03-31 $283,964 8,827